Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions - 20/06/24
Doi : 10.1016/S1473-3099(24)00352-9
Simon de Lusignan a, Ting Shi b, Tom Fowler c, d, Nick Andrews e, Dan Todkill f, Xinchun Gu a, Bernardo Meza-Torres a, Chris Robertson g, Aziz Sheikh b 
a Nuffield Department of Primary Care Health Sciences, University of Oxford Oxford, UK
b Usher Institute, University of Edinburgh, Edinburgh, UK
c UK Health Security Agency, London, UK
d William Harvey Research Institute, Queen Mary University of London, London, UK
e Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London, UK
f Real Time Syndromic Surveillance Team, Field Services, UK Health Security Agency, Warwick Medical School, University of Warwick
g Public Health Epidemiology, University of Strathclyde, Glasgow, G1 1XQ, Scotland
El texto completo de este artículo está disponible en PDF.
Crown Copyright © 2024
Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 24 - N° 7
P. e417-e418 - juillet 2024 Regresar al número
Artículo precedente
- Virological characteristics of the SARS-CoV-2 KP.2 variant
- Yu Kaku, Keiya Uriu, Yusuke Kosugi, Kaho Okumura, Daichi Yamasoba, Yoshifumi Uwamino, Jin Kuramochi, Kenji Sadamasu, Kazuhisa Yoshimura, Hiroyuki Asakura, Mami Nagashima, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Jumpei Ito, Kei Sato
- Correction to Lancet Infect Dis 2024; published online April 30. https://doi.org/10.1016/S1473-3099(24)00215-9
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?